AI holds potential to transform pharmacovigilance. But navigating the risks requires critical assessment. This article explores AI's evolving role in medicines safety.

Research / 22 October 2024

The READUS-PV statement is the first-ever guide for reporting disproportionality analyses that are replicable, reliable, and reproducible.

Research / 07 October 2024

Medication errors are a key pharmacovigilance issue, especially as patients transition between secondary and primary care as they readjust to life outside of hospital.

Research / 09 September 2024

Duplicate reports are a big problem when it comes to signal detection, but with the help of machine learning and new ways of comparing reports, we may more effectively detect them.

Research / 26 August 2024